Newsletter | June 5, 2025

06.05.25 -- Refresh Your CTA Strategy With Cybersecurity And EHRs In Mind

OUTSOURCING MODELS

Refresh Your CTA Strategy With Cybersecurity And EHRs In Mind, Part One

Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part one of this two-part series explores cybersecurity and EHR standards. 

Leverage Modeling And Simulation In The Candidate Development Stage

Modeling and simulation provides another way to predict the clinical performance of a molecule, based on a robust and holistic approach, before investing the required time and money.

Partnering With The Leading Global, Integrated CDMO

Leveraging a comprehensive range of services, from drug product development and manufacturing to commercial packaging and global launch can help you deliver therapies in a time-efficient manner.

Executive Q&A With SGS' Hudson, NH Bioanalytical Services Facility

Explore how SGS's Hudson facility can enhance your drug development process by providing cutting-edge bioanalytical testing solutions and seamless global support.

Support For Your Early-Stage Biotech Companies To Secure Funding

By combining strategic foresight, operational efficiency, and financial incentives, Avance Clinical empowers biotech companies to navigate funding challenges and bring innovative therapies to market.

Driving Early-Phase Success In Advanced Solid Tumors Study

A European biotech company collaborated with TFS HealthScience to conduct an early-phase clinical trial focusing on advanced and metastatic solid tumors.

Lock Into Your Go-To Data Strategy

Explore data solutions for every clinical study - whether you are engaging our comprehensive CRO services or require specific, functional solutions to support your project.

REGULATORY & COMPLIANCE

Here's Your 483 — And Your Hug

Former FDA inspector Tracey Harris shares what clinical sites get right, what they botch completely, and why inspection readiness is about more than coffee, binders, or bluffing.

Understand The FDA's Push For More Representation In Clinical Trials

Take action to improve diversity in clinical trials by addressing underrepresentation and ensuring equitable access to medical interventions, as emphasized by the FDA’s new 2025 guidance.

Proving The Return On Investment For eRegulatory

A study of how leading research centers, CROs, and sponsors cover the cost of eRegulatory tools... and then some.

Accelerate Your Oncology Breakthroughs

Finding the right partnership can help your oncology clinical trials overcome trial complexities through strategic planning, a deep scientific understanding, and operational excellence.

IQVIA Regulatory Affairs And Drug Development Solutions

Discover how offering sponsors end-to-end strategic drug development and technology-enabled regulatory services helps to reduce time, cost, and risk, from discovery through post-registration.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Thursday edition of the Clinical Leader newsletter, focusing on Outsourcing Models and Regulatory & Compliance. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: